News

President Donald Trump's new European tariffs may spell bad news for Novo Nordisk, maker of Ozempic and Wegovy. As Axios ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.
The Trump administration is considering a shift in health care coverage, allowing Medicare and Medicaid to cover GLP-1 weight loss drugs.
The chef said he is taking Wegovy to combat the effects of his bipolar medication, which he said has caused him to put on weight.
Iveco Group agreed to break itself up, selling its defence unit to Leonardo and the rest of the Italian truck maker to Tata Motors in deals totalling about €5.5bn.
Dubai: Once upon a time, brunch in Dubai was simple. You’d sit there with your crispy Avo egg toast and someone would ...
The deal “will bring stability. It will bring predictability”, said EU President Ursula von der Leyen at Donald Trump’s ...
As consumers drop pounds, beauty and wellness brands are dropping products in hopes of cashing in on the rise of weight-loss drugs.
The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Niacinamide, aka vitamin B3, helps strengthen the skin barrier, minimizes the appearance of pore size, reduces skin ...
Not packing in enough can cause muscle loss and a lower metabolism, and as the British Heart Foundation suggests, most adults ...